Readout Subscribe
Disclaimer. This site reads publicly available research papers and corporate filings and explains what they say. It is not investment advice and does not recommend buying or selling any security. Historical cases shown here are computed from public data; the sample sizes are small and are not a basis for prediction. We do not answer questions about individual stocks.
Readouts · Company page

Enchem

Company facts

Status
KOSDAQ 348370 · ISIN KR7348370008
Founded
2012-02-16
CEO
오정강
Headquarters
충청북도 제천시 바이오밸리로 107
Industry
KSIC 20119
Fiscal year end
12
Links
Filings · DART · Quote · finance.naver.com · Website
Source
DART

Financial summary (from filings)

202320242025
Revenue424,691365,709312,794
Operating income5,121−50,403−78,387
Net income−49,229−558,294−70,567
Total assets886,8791,159,8471,107,549
Total liabilities596,799675,005626,524
Total equity290,080484,842481,025

Unit: KRW million · Consolidated statements · Source DART 사업보고서
Figures are copied from the filing with only the unit changed. No growth rates or assessments are shown.

National R&D projects (NTIS)

26
item
18,139,700,000
Cumulative government R&D funding (KRW)

Largest projects

Korean patent filings (KIPRIS)

33
item

Recently published patents

Papers with affiliated authors (OpenAlex)

No records

Last updated 2026-09-21